Journal article Open access Published 2026

Baxdrostat: A First-in-Class Aldosterone Synthase Inhibitor for Resistant Hypertension

Imma Capriello, Alexander Dömling

ACS Pharmacology & Translational Science 9(4), 764-770 (2026)

Download PDF View on PubMed Cite

Cite this publication

CAPRIELLO, I., A. DÖMLING: Baxdrostat: A First-in-Class Aldosterone Synthase Inhibitor for Resistant Hypertension. ACS Pharmacology & Translational Science. 2026, 9(4), 764-770, ISSN: 2575-9108, PMID: 41988370,  PDF.

Details

ISSN
2575-9108

Authors from IMTM

WHERE TO FIND US

Hněvotínská 1333/5
779 00 Olomouc
Czech Republic

+420 585632111
+420 585632180
recepce.umtm@upol.cz
info@imtm.cz

GPS: 49° 35´ 10.1869512" N, 17° 14´ 6.292305" E

ABOUT IMTM

Our mission is to perform basic and translational biomedical research with an aim to better understand the underlying cause of human infectious diseases and cancer, and to develop future human medicines, medical devices and diagnostics. Our vision is to facilitate private-public partnership and research collaboration, and to integrate member researchers into international platforms. LEARN MORE ABOUT IMTM

HELPDESK PORTAL
© 2026 Institute of Molecular and Translational Medicine

This website uses cookies

We use necessary cookies to make the website work. With your consent we also use analytics cookies and show embedded content from other services that may set their own cookies. You can change your choice at any time under "Cookie settings" at the bottom of every page. Privacy policy

Cookie settings

Choose which cookies we may use. Your choice is stored for 6 months. Privacy policy

  • Required for the website to work – e.g. your session when logged in, security and remembering this choice. They cannot be switched off.

  • Help us understand how visitors use the website so we can improve it (Google Analytics, anonymised IP address).

  • Show content embedded from YouTube, X (Twitter), Facebook, Google Maps and Czech Radio. These services may set their own cookies.